Differential regulation of interleukin-1 receptor antagonist by proopiomelanocortin peptides adrenocorticotropic hormone and β-endorphin

NeuroImmunoModulation

Volumn 6, Issue 5, 1999, Pages 367-372

  Kovalovsky, Damián ^a   Pereda, Marcelo Páez ^b   Stalla, Günter K ^b   Holsboer, Florian ^b   Arzt, Eduardo ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Endorphin; Adrenocorticotropic hormone; Glucocorticoids; Interleukin 1; Interleukin 1 receptor antagonist

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; INTERLEUKIN 1 RECEPTOR; PROOPIOMELANOCORTIN;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOREGULATION; MONOCYTE; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; BETA-ENDORPHIN; BLOTTING, NORTHERN; CELLS, CULTURED; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MONOCYTES; PRO-OPIOMELANOCORTIN; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0032844630     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026397     Document Type: Article

References (41)

1. Besedovsky H, del Rey A: Immune-endocrine circuits: Integrative role of cytokines. Front Neuroendocrinol 1992;13:61-94.
2. Dinarello CA: Role of interleukin-1 in infectious diseases. Immunol Rev 1992;127:119-146.
3. Bateman A, Singh A, Kral T, Solomon S: The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989;10:92-111.
4. Rossier J, Franch ED, Rivier C, Ling N, Gillemin R, Bloom FE: Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature 1977;270:618-620.
5. Moretti C, Perricone R, De Sanctis G, De Carolis C, Fabbri A, Gnessi L, Fraioli F, Fontana L: Endorphins: Evidence of Multiple Interactions with the Immune System. Amsterdam, Elsevier Science, 1984, pp 137-157.
6. Johnson EW, Blalock JE, Smith EM: ACTH receptor-mediated induction of leukocyte cyclic AMP. Biochem Biophys Res Commun 1988;157:1205-1211.
7. Smith EM, Brosnan MD, Meyer WJ, Blalock JE: An ACTH receptor on human mononuclear leukocytes: Relation to adrenal ACTH-receptor activity. N Engl J Med 1987;317: 1266-1269.
8. Clarke BL, Bost KL: Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes. J Immunol 1989;143:464-469.
9. Haugecn SE, Wilk P: Glucocorticoid and ACTH regulation of rat peritoneal phagocyte chemiluminescence and nitric oxide production in culture. Acta Physiol Scand 1997;161:93-101.
10. Johnson HM, Torres BA, Smith EM, Dion D, Blalock J: Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol 1984;132:246-250.
11. Koff WC, Dunegan MA: Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 1985;135:350-354.
12. Morch H, Pedersen BK: β-Endorphin and the immune system - Possible role in autoimmune diseases. Autoimmunity 1995;21:161-171.
13. Roda LG, Bongiorno L, Trani E, Urbani A, Marini M: Positive and negative immunomodulation by opioid peptides. Int J Immunopharmacol 1996;18:1-16.
14. Bessler H, Sztein MB, Serrate SA: β-Endorphin modulation of IL-1 induced IL-2 production. Immunopharmacology 1990;19:5-14.
15. Lieb K, Fiebich BL, Busse-Grawitz M, Hüll M, Berger M, Bauer J: Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1β and interleukin-6 in human monocytes: A re-examination. J Neuroimmunol 1996;67:77-81.
16. Carr DJJ: Opioid receptors on cells of the immune system. PNEI 1988;1:8-14.
17. Sharp BM, Shahabi NA, Heagy W, Mcallen K, Bell M, Hunton C, McKean DJ: Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc Natl Acad Sci USA 1996;93:8294-8299.
18. Alicea C, Belkowski S, Eisenstein TK, Adler MW, Rogers TJ: Inhibition of primary murine macrophage cytokine production in vitro following treatment with the k-opioid agonist U50, 488H. J Immunol 1996;64:83-90.
19. Radulescu RT, De Costa BR, Jacobson AE, Rice KC, Blalock JE, Carr DJJ: Biochemical and functional characterization of a μ-opioid receptor binding site on cells of the immune system. Prog Neuroimmunol 1991;4:166-179.
20. Hucklebridge FH, Hudspith BN, Muhamed J, Ludyard PM, Brostoff J: Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via delta-opioid receptors. Brain Behav Immun 1989;3:183-189.
21. Hucklebridge FH, Hudspith BN, Lydyard PM, Brostoff J: Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogues. Immunopharmacology 1990;19:87-91.
22. Carr DJJ, De Costa BR, Kim CH, Jacobson AE, Guarcello V, Rice KC, Blalock JE: Opioid receptors on cells of the immune system: Evidence for δ and κ classes. J Endocrinol 1989; 122:161-168.
23. Hazum E, Chand K, Cuatrecasas P: Specific non-opiate receptors for β-endorphin. Science 1979;205:1033-1035.
24. Arend WP: Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J Clin Invest 1991;88:1445-1451.
25. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990;343: 341-346.
26. Andersson J, Björk L, Dinarello CA, Towbin H, Andersson U: Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol 1992;22:2617-2623.
27. Arzt E, Sauer J, Pollmächer T, Labeur M, Holsboer F, Reul J, Stalla GK: Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. Endocrinology 1994;134:672-677.
28. Kovalovsky D, Páez Pereda M, Sauer J, Perez Castro C, Nahmod VE, Stalla GK, Arzt E: The Th1 and Th2 cytokines IFN-γ and IL-4 antagonize the inhibition of monocyte IL-1 receptor antagonist by glucocorticoids: Involvement of IL-1. Eur J Immunol 1998;28:2075-2085.
29. Paez Pereda M, Perez Castro C, Costas M, Nahmod VE, Stalla GK, Holsboer F, Arzt E: Glucocorticoids inhibit the autoregulatory induction of interleukin-1 in monocytes after endotoxin stimulation. Neuroimmunomodulation 1996;3:227-232.
30. Paez Pereda M, Sauer J, Perez Castro C, Finkielman S, Stalla GK, Holsboer F, Arzt E: Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology 1995;136:5504-5510.
31. Sauer J, Castrén M, Hopfner U, Holsboer F, Stalla GK, Arzt E: Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: Involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab 1996;81:73-79.
32. Arzt E, Fernández CS, Finocchiaro L, Criscuolo M, Diaz A, Finkielman S, Nahmod VE: Immunomodulation by indoleamines: Serotonin and melatonin action on DNA and interferon gamma synthesis by human peripheral blood mononuclcar cells. J Clin Immunol 1988;8:513-519.
33. Arzt E, Stelzer G, Renner U, Lange M, Müller OA, Stalla GK: Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures. J Clin Invest 1992;90:1944-1951.
34. Johnson HM, Smith EM, Torres BA, Blalock JE: Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci USA 1982;79:4171-4174.
35. Fischer E, Van Zee KJ, Marano MA, Rock CS, Kenney JS, Poutsiaka DD, Dinarello CA, Lowry SF, Moldawer LL: Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 1992;79: 2196-2200.
36. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-I and glucocorticoid hormones. Science 1986;233:652-654.
37. Catania A, Lipton MJ: The neuropeptide alpha-melanocyte-stimulating hormone: A key component of neuroimmunomodulation. Neuroimmunomodulation 1994;1:93-99.
38. Apte RN, Oppenheim JJ, Durum SK: Beta-endorphin regulates interleukin 1 production and release by murine bone marrow macrophages. Int Immunol 1989;1:465-470.
39. Morch H, Pedersen BH: β-Endorphin and the immune system - Possible role in autoimmune diseases. Autoimmunity 1995;21:161-171.
40. Ruff MR, Wahl SM, Mergenhagen S, Pert CB: Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides 1985;5:363-366.
41. Perez-Castrillon JL, Perez-Arellano JL, Garcia-Palomo JD, Jimenez-Lopez A, De Castro S: Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology 1992;23:57-61.